Purpose: To evaluate the spectrum of acute infectious encephalitis/encephalopathy syndrome (AIES) in intensive care unit (ICU) and the predictors of mechanical ventilation (MV) and outcome of these patients. Methods: AIES patients diagnosed on the basis of fever, altered sensorium, seizure and cerebrospinal fluid pleocytosis admitted to the neurology ICU were prospectively included. The demographic and clinical details, hematological, biochemical, MRI and etiological findings of the patients were noted. Need of MV, death in hospital and 3-month functional outcome were analyzed. Results: One hundred sixty-four out of 258 (64%) AIES patients needed ICU admission. Their median age was 35 (2-85) years and 71 (43%) were females. The etiology was viral in 44 (herpes and Japanese encephalitis in 12 each, dengue in 17, mumps, measles and varicella in 1 patient each), non-viral in 64 (scrub typhus in 48, falciparum malaria in 6, leptospira in 3 and bacterial in 7) and undetermined etiology in 56 (34%) patients. Sixty-nine (42%) patients needed MV. On multivariate analysis, Glasgow Coma Scale (GCS) score, Sequential Organ Failure Assessment (SOFA) score and raised intracranial pressure were independent predictors of MV. Forty-three (26%) patients died, and all were in the MV group. Higher SOFA score and untreatable etiology were independent predictors of mortality. At 3-month follow-up, 14% had poor and 86% had good outcome. Low GCS score, focal weakness and status epilepticus independently predicted poor outcome. Conclusion: Twenty-six percent patients with AIES died in ICU, and 86% had good recovery at 3 months. Admission SOFA scores and untreatable etiology predicted mortality.
Introduction
Acute infectious encephalitis/encephalopathy syndrome (AIES) is characterized by fever with impaired consciousness ranging from confusion to coma. This may be associated with seizures other than common febrile seizures.
1 AIES may be due to viral, bacterial, fungal, rickettsial, spirochetal or parasitic infections. Autoimmune encephalitis may also simulate AIES but have different clinical presentation, different etiology and responds to immunotherapy. The spectrum of AIES varies in different geographical regions because of differences in circulating organisms. During the post-monsoon period, a number of arboviruses result in outbreaks of encephalitis in tropical countries. In South-East Asia, Japanese encephalitis (JE) is diagnosed in about 67 900 cases annually, and 50% of them die. 2 Dengue occurs in about 100 million people annually; 500 000 are diagnosed with severe dengue-dengue hemorrhagic fever/dengue shock syndrome (DSS) and 25 000 of them die. 3, 4 The annual incidence of herpes simplex encephalitis (HSE) is 1-2 per million without any geographical or seasonal preference. Untreated HSE has high mortality, which has been substantially reduced by acyclovir therapy. 5 Mortality in encephalitis patients is secondary to raised intracranial pressure (ICP), status epilepticus (SE), aspiration pneumonia and/or autonomic instability. [6] [7] [8] [9] In dengue, chikungunya, malaria, leptospirosis and rickettsial infections, death may occur due to bleeding and refractory hypotension complicated by myocardial dysfunction. The patients with dengue, JE and West Nile encephalitis may present with acute flaccid weakness that may contribute to respiratory failure. [10] [11] [12] [13] [14] Infectious encephalitis is generally a monophasic illness, and many patients survive with variable outcome if they are supported by intensive care and mechanical ventilation (MV) whenever needed. 9, [15] [16] [17] There is paucity of information regarding the spectrum and outcome of AIES patients treated in ICU, especially among those needing MV. In this study, we report the spectrum of AIES patients requiring ICU care and the predictors of MV in them along with their predictors of death and functional outcome.
Materials and methods

Study design
Patient selection and approvals This prospective study was conducted in a tertiary care teaching hospital in North India between 2012 and 2014 and was approved by the Institute Ethics Committee SGPGIMS, Lucknow (India).
Inclusion criteria
Consecutive patients with AIES admitted to the neurology ICU were included. Encephalitis was diagnosed on the basis of fever, impaired consciousness and cerebrospinal fluid (CSF) pleocytosis with or without seizure and focal neurological deficit. 7 CSF
could not be studied in the patients with severe coagulopathy, thrombocytopenia and those who died within 12 h. Patients with normal CSF were considered acute infectious encephalopathy. Critically ill patients especially those with respiratory failure, hypotension, Glasgow Coma Scale (GCS) score 8, features of raised ICP, SE and bleeding diatheses were admitted in the ICU.
Exclusion criteria
Patients with proven etiology other than infection such as central nervous system (CNS) vasculitis, mitochondrial disease, autoimmune encephalitis and chronic meningitis were excluded.
Clinical evaluation
Demographic information about age, gender and residential details were recorded. Clinical information regarding the duration of illness, presence of fever, headache, vomiting, altered sensorium, bleeding diathesis and respiratory symptoms were noted. Blood pressure, pulse rate, jaundice, edema, lymphadenopathy, flushing, skin rash and bleeding diathesis (ecchymosis, epistaxis, gastrointestinal bleed and sub-conjunctival hemorrhage) were noted. Enlargement of the liver or spleen, ascites, chest rales and cardiac findings was noted. Consciousness was assessed using the GCS. Features of raised ICP such as hyperventilation, extensor posturing and pupillary asymmetry were noted. Details of cranial nerve palsies, papilledema, muscle tone, limb weakness, tendon reflex and plantar response were also recorded. Abnormal movements including myoclonus, chorea, dystonia and tremor were also noted.
Investigations
Hemoglobin, hematocrit, blood counts, erythrocyte sedimentation rate, prothrombin time, activated partial thromboplastin time, blood sugar, blood urea nitrogen, serum creatinine; sodium, potassium, calcium, bilirubin, alanine transaminase (AST), alkaline phosphatase (ALP) and creatine kinase were measured in all the patients. ECG, chest radiograph, arterial blood gas (ABG) analysis, blood cultures and HIV serology were done. Cranial MRI was done within 48 h of admission using 3 T SIGNA GE Medical System, Wisconsin, USA. T1, T2, fluid attenuated inversion recovery (FLAIR) and T1 contrast images were obtained. The location and extent of lesions were noted. Electroencephalography was done using the 10-20 system of electrode placement. The background activity, asymmetry in frequency and voltage and epileptiform activity were noted. CSF was examined for cells, protein and sugar. In the patients with severe coagulopathy or thrombocytopenia, the CSF examination was deferred till these were normalized.
Etiological diagnosis
The AIES patients were screened for prevalent infections reported from Northern India. After the initial clinical and laboratory assessment, patients were divided into pure neurological AIES and AIES with systemic manifestations (Figure 1 ). CSF gram stain, Zeihl-Neelson stain, fungal stain and cultures were done for bacteria, Mycobacterium tuberculosis and fungi. Patients with pure neurological AIES underwent testing for HSV, JE virus, varicella zoster virus (VZV), mumps and measles virus. CSF PCR testing was done for HSV and JE, IgM ELISA for HSV, JE, VZV, mumps and measles. Patients with systemic manifestations like rash, thrombocytopenia and renal or hepatic dysfunction underwent testing for malaria, dengue, scrub typhus, leptospira and chikungunya. Serological (ELISA) studies were done for dengue (NS1 antigen and IgM), chikungunya (IgM) and leptospira (IgM). Blood was tested for scrub typhus using immune chromatographic assay and/or the Weil Felix test. Peripheral blood smear was examined for malarial parasite. The AIES patients in whom the above-mentioned tests were negative were categorized as AIES with undetermined etiology. AIES patients were further categorized to treatable (HSE, HZV, scrub typhus, malaria, pyogenic meningitis and leptospira) and untreatable (JE, dengue, mumps, measles, chikungunya and undetermined). Fifteen patients with autoimmune encephalitis were excluded.
Intubation and MV
Patients with AIES were intubated and mechanically ventilated if unable to maintain oxygen saturation on the Venturi-mask or if there were abnormalities on ABG analysis such as pH < 7.3, PaO 2 < 60 mm Hg and PaCO 2 > 50 mm Hg. 15 Oxygen saturation, pulse rate and blood pressure were monitored continuously. Blood counts, chest radiograph and cultures of blood, urine and endotracheal secretions were obtained as indicated. The duration of MV, hospital stay and ventilator related (ventilatoracquired pneumonia, atelectasis and pneumothorax), and other ICU-related complications (deep vein thrombosis, pressure sores, urinary tract infections, catheter related blood stream infections and psychosis) were noted. We allowed one caregiver to stay by the patient's bed side. The Sequential Organ Failure Assessment (SOFA) score was computed to document the extent of organ dysfunction on admission.
Treatment
In the patients suspected to have HSE or varicella zoster encephalitis, acyclovir 10 mg/kg/8 hourly was given i.v. for 14 days. Scrub typhus was treated with doxycycline 100 mg twice daily for 7 days, leptospira with ceftriaxone 1 g twice daily i.v. for 7 days, and malaria with i.v. artesunate 2.4 mg/kg at admission, at 12 and 24 h then once daily till consciousness was regained. Thereafter, oral artemether in combination with lumefantrine was given for another 3 days. 18 In dengue patients, hypotension was treated by crystalloid or colloid infusion. The patients with coagulopathy were treated with fresh frozen plasma, and those with thrombocytopenia having bleeding diathesis were treated with platelet transfusion. Symptomatic treatment for the complications of encephalitis was given, such as raised ICP was treated with 100 ml of 20% mannitol, SE with intravenous lorazepam, valproate and levetiracetam and fever with paracetamol and tepid sponging. Fluid, electrolyte and calorie requirements were met with.
Outcome assessment
Primary outcome was defined as death during hospital stay, and secondary outcome was assessed using modified Rankin Scale (mRS) score at 3-month follow-up, and categorized as poor (mRS score, 3-6) or good (mRS 0-2). 15 
Statistical analysis
The frequency of in-hospital death and poor outcome at 3 months was compared with demographic, etiology of encephalitis, SOFA score, GCS score, liver and kidney dysfunction, thrombocytopenia, MRI and EEG findings, duration of MV, and ICU complications using Fisher exact test for categorical variables and the independent-'t' or Mann-Whitney U test for continuous variables. Variables having a P values < 0.1 were included in the multivariate logistic regression analysis for predicting death and functional outcome at 3 months. Predictors of MV were also evaluated by multiple logistic regression analysis. The variable was considered significant if the 2-tailed P values was <0.05. The statistical analyses were done using SPSS version 16 and GraphPad Prism 5 software.
Results
There were 258 patients with AIES admitted between 2012 and 2014. One hundred and sixty-four (64%) of them required intensive care and were included in the present study. Their age ranged between 2 and 85 (median, 35) years; 24 (15%) of them were above 65 years and 29 (18%) below 15 years of age. Sixty-one (43%) of these patients were females. Most (113; 69%) of the patients were from the villages of Eastern Uttar Pradesh and Bihar, India. Patients were admitted after a median of 11 (1-30) days of illness, and 54 (33%) of them were admitted within a week. The etiology of AIES was viral in 44 (27%),
non-viral in 64 (39%) and undetermined in 56 (34%) patients. CSF was done in 122 patients and was abnormal in all except 9 patients, and revealed lymphocytic pleocytosis with raised protein. The etiological diagnosis of the patients and their CSF findings are shown in Figures 1 and 2 . Cranial MRI was done in 113 and was abnormal in 52 patients. All the 12 patients with JE revealed bilateral thalamic lesion, and additional lesions were seen in subcortical white mater in 6, basal ganglia in 3, mid brain in 2 and temporal lobe and cerebellar lesion in 1 patient each. Cranial MRI was abnormal in all 12 patients with HSE and revealed bilateral temporal lobe involvement in all, basifrontal in 4 and insular cortex in 2 patients. In scrub typhus, 4 out of 39 MRIs were abnormal and revealed intracerebral hemorrhage in 2, subcortical white matter T2 hyperintensity in 1 and incidental left cerebello-pontine meningioma in 1 patient. In the remaining 25 patients, MRI abnormalities were nonspecific white matter T2 hyperintensity.
MV
Sixty-nine of 164 (42%) patients had respiratory failure and needed MV. The patients in the ventilated group were older and had clinical evidences of raised ICP, lower GCS score and systolic blood pressure and higher frequency of seizures, focal weakness and areflexia compared to the non-MV group. The laboratory investigations revealed higher blood leukocyte counts, serum creatinine, creatine kinase, and international normalized ratio (INR) in the MV group compared to that in the non-MV group. However, platelet counts and serum albumin were lower in the MV group. The details are presented in Table 1 . AIES patients with treatable etiologies needed MV less frequently than those with untreatable etiologies. The etiology-wise breakup of AIES patients requiring MV is presented in Figure 1 . 
Complications in ICU
Ventilator-related complications were present in 32/69 (46%) patients and included ventilator-associated pneumonia in 28, atelectasis in 20, pneumothorax in 1 and pulmonary embolism in 1 patient. Other complications in ICU patients included SE in 62 (38%), urinary tract infection in 10 (6%), deep vein thrombosis in 5 (3%) and pressure sores in 13 (8%) patients, which were not different between MV and non-MV groups (Table 3) . Interestingly, none of our patients developed ICU psychosis.
Outcome
Forty-three patients with AIES (26%) died, and all were in the MV group. The mortality in encephalitis patients with respect to underlying etiology is shown in Figure 3 . The immediate cause of death was raised ICP and brain herniation in four patients, pulmonary embolism in one, and septicemia in two. On comparing the patients who died with those who survived, it was found that the survivors were younger (34.66 21.2 vs. 43.4 6 21.7 years; P ¼ 0.02), had higher GCS score (9.9 6 3.3 vs. 6.7 6 3.1; P < 0.001) and lower incidence of hypotension (21% vs. 37%; P ¼ 0.04), respiratory failure (22% vs. 100%; P < 0.001), pneumonia (60% vs. 91%; P < 0.001), septicemia (5% vs. 16%; P ¼ 0.04) and bleeding diathesis (26% vs. 65%; P < 0.001). The patients who survived had lower SOFA score than those who died (6.8 6 4.3 vs. 11.9 6 4.3; P < 0.001). They also had lower frequency of Table 2) . Seven out of 41 (17%) patients with scrub typhus died; 3 of them were diagnosed postmortem. All had multi-organ dysfunction, and two had intracranial hemorrhage (subdural in one and lobar bleed in another). Patients with dengue (7/10) also had a higher than expected mortality; all were referred late, had DSS and multi-organ dysfunction, needing dialysis and MV and one patient had severe myositis and myocarditis as well. The AIES patients with undetermined (39%) and viral etiology (30%) had higher mortality than those with non-viral AIES (13%). In AIES patients, systemic manifestations were less common in viral encephalitis (25%) compared with non-viral (95%) and undetermined (75%) groups. Most of the patients died within 10 days of hospitalization (8.0 6 11.2 days). Early admission (within 7 days of illness) vs. late admission was not related to death. The surviving patients were admitted for a median duration of 12 (1-236) days.
Among the survivors, 7 were lost to follow-up, and the remaining 114 patients were followed up at 1 and 3 months. At 3 months, 16 patients (14%) had poor and 98 (86%) had good functional outcome. On multivariate analysis, low GCS score (OR, 1.21; 95% CI, 1.00-1.47; P ¼ 0.05), focal weakness (OR, 0.08; 95% CI, 0.01-0.67; P ¼ 0.02) and SE (OR, 0.25; 95% CI, 0.07-0.84; P ¼ 0.03) were independent predictors of poor functional outcome at 3 months ( Table 2 ).
Discussion
In our study, 64% AIES patients needed ICU care, and 42% needed MV. On multivariate analysis, SOFA score, GCS score, thrombocytopenia and raised ICP on admission predicted MV. Twenty-six percent of our patients died, and the independent predictors of mortality were SOFA score and undetermined etiology of AIES. This is the first study from a developing country, which reports the spectrum and outcome of AIES patients needing intensive care. In a retrospective study on 103 encephalitis patients from an ICU in USA, the etiology was viral in 27.2%, bacterial and fungal in 9.7%, autoimmune in 16.5% and undetermined in 46.6% patients. Seventeen out of 28 patients with viral encephalitis had HSE. Mortality was related to cerebral edema, thrombocytopenia and SE. In this study, 95% of MV patients died. 9 In another retrospective study on 198 patients with acute encephalitis, 50.5% patients with viral encephalitis, 40.5% in autoimmune and 54.2% with unknown etiology had good outcome on discharge. The mortality was 8% in viral, 12% in autoimmune and 15% in unknown groups. Poor outcome was related to old age (65 years), immune compromised state, MV, thrombocytopenia and CSF polymorphonuclear leukocytosis. 17 In this study, the patients with transplantation, AIDS, cancer chemotherapy and autoimmune encephalitis were also included. These studies, however, did not evaluate the predictors of MV. Both the studies also did not evaluate the MV patients separately and role of SOFA score in their outcome. The SOFA score is a measure of multiple organ dysfunctions and predicts the severity and outcome of critically ill patients. 19 In a study on scrub typhus, the need of MV was predicted by acute respiratory failure, SOFA score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, platelet count and lactate dehydrogenase. 20 About one-fourth patients with scrub typhus admitted in ICU died, and the APACHE II, SOFA score and procalcitonin level were independent predictors of mortality.
21
, 22 In the present study, the SOFA score on admission was found to predict MV and mortality but not 3-month outcome. In our study, 41% of AIES patients with dengue died. However, all these patients had dengue encephalitis, multiorgan failure and DSS and they were referred late (median 2 days from the onset of DSS). The reported mortality in DSS range between 1 and 50%. 23 , 24 CNS involvement in dengue is suggestive of severe dengue infection, and when associated with shock and multi-organ dysfunction, increases the chance of death. 25 The clinical picture of dengue is similar to that of scrub typhus. In our study, 7 out of 48 encephalitis patients with scrub typhus died; 2 of whom were diagnosed after death, and 1 was referred late. All these patients had severe coagulopathy, thrombocytopenia, renal failure and CSF pleocytosis. In scrub typhus, the case fatality rate in untreated patients has been reported to range between 3 and 60% patients. 26 , 27 Scrub typhus is a treatable condition and responds well to doxycycline. In a study, 89 patients with severe scrub typhus were compared with 119 patients without severe complications. The severity of scrub typhus correlated with age, absence of eschar, leukocytosis and hypoalbuminemia. Only one patient died. 26 In our earlier study on 37 patients with scrub typhus, all the patients recovered completely within 1 month. 28 In the present study, 3 out of 12 patients with HSE died, and the remaining 9 patients had variable recovery. In a study on HSE patients, 71% needed ICU care, and 45% of them were mechanically ventilated. 15% patients died, and 20% had severe neurological disability. 29 In the present study, SOFA score predicted MV and mortality, and GCS scores predicted MV and 3-month outcome. In patients with encephalitis, respiratory failure may be due to central causes such as brainstem involvement and brain herniation or due to associated muscle dysfunction. In dengue and scrub typhus, transient muscle dysfunction and inflammatory myositis have been reported respectively. 30, 31 Seizures occurred in 51% of our patients and led to MV in 50% patients. Seizures and SE in encephalitis may be intractable and may lead to MV by elevating ICP resulting in brain herniation. In a study on SE in viral encephalitis, 36.7% patients responded to second-line drugs and one-third patients died. 32 In the present study, however, SE was not related to mortality, which may be due to differences in the pathophysiology. In HSE, there may be hemorrhagic necrotizing changes in the temporo-frontal cortex, which is highly epileptogenic. 33 However, in dengue, scrub typhus and malaria, there may be milder changes, and MRI is typically normal or may reveal nonspecific abnormalities.
28
, 34 , 35 JE primarily involves the thalamus, basal ganglia and brainstem, and in 13.6% patients it may involve cortical areas including temporal lobe. 36 In a study on 148 patients with viral encephalitis, seizure occurred in the acute stage in 42.6% patients. Seizure was commoner in HSE (75%) than in JE (54%). The predictors of seizure were younger age, GCS score and cortical involvement on MRI. 7 None of our patients developed ICU psychosis, as we allowed one caregiver by the bedside. However, our patients had higher incidence of other complications that may be attributed to the disease per se. In our experience, ICU-related complications in diseases such as myasthenia gravis and Guillain-Barre syndrome are comparable with other centers.
37
, 38 The present study is limited by the lack of intra-arterial and ICP monitoring. In a recent study, however, on early goaldirected treatment of sepsis, intra-arterial blood pressure monitoring was not found to change the outcome. 39 The use of advanced molecular diagnostic facilities might have provided clues to specific diagnosis and possibly specific treatment in the group we classified as undetermined etiology. This study has a referral bias, as it was conducted in a tertiary care referral center, where high proportion of critically ill patients and those with advanced illness are referred. Very few children were included in our study because ours is mainly adult neurology practice.
Conclusions
In the present, the mortality of AIES patients in ICU was 26% and 86% of survivors had good outcome at 3 months. Admission GCS score predicted MV and functional outcome, and SOFA score predicted MV and mortality.
